5-Aminosalicylic Acid
5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN) .
Product Specifications
CAS Number
[89-57-6]
Product Name Alternative
Mesalamine; 5-ASA; Mesalazine
UNSPSC
12352005
Hazard Statement
H315, H317, H319, H335
Target
Endogenous Metabolite; NF-κB; PAK; PPAR
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Metabolic Enzyme/Protease; NF-κB; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/5-Aminosalicylic-acid.html
Purity
99.97
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OC1=C(C(O)=O)C=C(N)C=C1
Molecular Formula
C7H7NO3
Molecular Weight
153.14
Precautions
H315, H317, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
RT, protect from light, stored under nitrogen
Badge
Hot
Scientific Category
Natural Products
Clinical Information
Launched
Isoform
PAK1; PPARγ; RelA/p65
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
UBE2DNL (MGC42638, Putative Ubiquitin-conjugating Enzyme E2 D2-like Protein, Ubiquitin Carrier Protein D2-like, Ubiquitin-conjugating Enzyme E2D N-terminal-like, Ubiquitin-protein Ligase D2-like, UBE2D2L) (MaxLight 550)
UBE2DNL (MGC42638, Putative Ubiquitin-conjugating Enzyme E2 D2-like Protein, Ubiquitin Carrier Protein D2-like, Ubiquitin-conjugating Enzyme E2D N-terminal-like, Ubiquitin-protein Ligase D2-like, UBE2D2L) (MaxLight 550)
SGPP2, NT (SGPP2, Sphingosine-1-phosphate phosphatase 2, Sphingosine-1-phosphatase 2) (PE) discontinued
